Literature DB >> 12956307

Comparison of ABR stimuli for the early detection of ototoxicity: conventional clicks compared with high frequency clicks and single frequency tonebursts.

Stephen A Fausti1, Christopher L Flick, Alison M Bobal, Roger M Ellingson, James A Henry, Curtin R Mitchell.   

Abstract

Effective objective testing methodology is needed for early detection of the effects of ototoxicity on hearing in patients. The requirements for such testing include responses that are: 1) reliable across test sessions; 2) sensitive to ototoxic change ( > 8 kHz), and 3) recordable in a time-efficient manner. Auditory brainstem responses (ABR) appear well suited to this task however, conventional clicks stimulate primarily mid-frequencies (1-4 kHz) and high frequency tonebursts require too much time. We hypothesized that delivery of a band of high frequencies (a high frequency "click"), would elicit reliable and useful ABRs. In the current study, flat and sloped HF (high frequency) clicks with a bandwidth of 8-14 kHz were used. The purpose was to compare brainstem responses elicited by tonebursts, two HF clicks and conventional clicks. The results show that the reliability of responses to the HF clicks were comparable to the tonebursts and further, both HF clicks produced responses slightly larger than tonebursts.

Entities:  

Mesh:

Year:  2003        PMID: 12956307

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  6 in total

1.  Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.

Authors:  Angela C Garinis; Douglas H Keefe; Lisa L Hunter; Denis F Fitzpatrick; Daniel B Putterman; Garnett P McMillan; Jeffrey A Gold; M Patrick Feeney
Journal:  Ear Hear       Date:  2018 Jan/Feb       Impact factor: 3.570

Review 2.  Monitoring Protocols for Cochlear Toxicity.

Authors:  Sherman G Lord
Journal:  Semin Hear       Date:  2019-04-26

3.  Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria.

Authors:  Gabriel Carrasquilla; Clemencia Barón; Edwin M Monsell; Marc Cousin; Verena Walter; Gilbert Lefèvre; Oliver Sander; Laurel M Fisher
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

4.  Clinical Utilisation of High-frequency DPOAEs.

Authors:  Gayla Poling; Jungmee Lee; Jonathan Siegel; Sumitrajit Dhar
Journal:  ENT Audiol News       Date:  2012 Sep-Oct

Review 5.  Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed?

Authors:  Virginia Ramos-Martín; Carmen González-Martínez; Ian Mackenzie; Joachim Schmutzhard; Cheryl Pace; David G Lalloo; Dianne J Terlouw
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

6.  Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.

Authors:  Verena I Carrara; Aung P Phyo; Paw Nwee; Ma Soe; Hsar Htoo; Jaruwan Arunkamomkiri; Pratap Singhasivanon; François Nosten
Journal:  Malar J       Date:  2008-11-06       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.